Documente Academic
Documente Profesional
Documente Cultură
NANOTECHNOLOGY
INTRODUCTION
Swift advancement in fabrication of nanoparticles having identical size, composition and shape
have started uprising in the field of pharmaceutical sciences. From the last decade, development
of nano size based drug delivery systems has attracted augmented attention of researchers. In fast-
developing field of nanotechnology nano size based drug delivery systems are leading due to
numerous potential uses in pharmaceutical drug delivery and other fields of sciences. Because of
unique size dependent properties, these drug delivery systems offers the opportunity to develop
novel ways for treating diseases. The assimilation of drugs into nano carrier systems gives a new
archetype in drugs delivery, used for drug targeting at secondary and tertiary levels. These drug
delivery systems as oral dosage form, potentially enhance the lymphatic transport, thus reducing
ABOUT PROJECT
In this project efforts will be made for Selection of excipients/carrier systems including lipids,
solubility of different drugs, assessment of different approaches developed for the solubility
enhancement , dissolution followed by intestinal permeability for drugs and some other parameters
such as compatibility studies, spectral analysis and stability studies by using different techniques
like Zeta Sizer, Scanning Electron Microscopy(SEM), Transmission Electron Microscopy (TEM),
Diffraction (XRD), Atomic Force Microscopy (AFM) etc followed by dosage form designing,
Evaluation of approaches for extent of upgrading of these parameters , assessment of suitable
Conventional formulation strategies may no longer be enough for poorly aqueous soluble drugs
emerged from drug discovery. In recent pharmaceutics, sophisticated drug delivery approaches
such as nano size based drug delivery systems become a vital technology in the development of
new drug entities. In addition to improving solubility and bioavailability, these drug delivery
systems also offer many other clinical advantages over conventional formulations for many poorly
compounds
dose flexibility
e. Elimination or decrease of inter- and intra- subject variability because of reduced effects
Nano drug delivery is also a smart option for controlled drug release and targeted drug delivery.
Using molecular assembly and coating technologies, formulations can be designed to tailor a
Activity
Activities
Number 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter
material
2. Preparation of
Nanoparticles by using
different techniques
Characterization of
Nanoparticles by
SEM/TEM/Zeta sizer
etc
Characterization of
3.
nanoparticles by AFM,
Documentation and
Publication
RESEARCH OUTCOMES
multidisciplinary field with great scope and immense potential in numerous areas such as
engineering, agriculture, food science, etc. Our research deals with the preparation of nano size
based drug delivery systems by cost effective methods for drugs having low bioavailability which
TO ME AND MY UNIVERSITY
Advance my education through various learning opportunities, both formally and through
projects and research activities, which will be determined in collaboration with Prof. Zihei
Publish many original research results obtained during my tenure in appropriate journals
Attend scientific conferences agreed between me and my supervisor to present our results
Current proposal will also prove quite effective in strengthening our institutional facilities on
pharmaceutical sciences. Moreover, our experimental data resulting from the proposed
research will be of great worth which can be shared at national/international scientific forum
for reflection of our quality research. From this project, it is expected that at least two
acquired data in internationally reputed journals of impact factor is an integral part of our
scientific data sharing plan. We expect that more than three research articles can be generated
Positive opinion will be established about pharmaceutical industries by giving them new
methods for the development of cost-effective drug delivery system. It will help in
REFERENCES
1. Triplett II MD, Rathman JF. Optimization of β-carotene loaded solid lipid nanoparticles
Research. 2009;11(3):601-614.
3. Patidar A, Thakur DS, Kumar P, Verma J. A review on novel lipid based nanocarriers.
4. Mahon E, Salvati A, Bombelli FB, Lynch I, Dawson KA. Designing the nanoparticle–
Release. 2012;161(2):164-174.
antitumor activity by blocking multiple signaling pathways of cancer stem cells. Chinese
8. Wu Y-Q, Yang T-S, Li X, et al. Novel derivatives of niclosamide synthesis: Its bioactivity
2011;88(3):326-332.
phosphorylation. 1969.
10. Osada T, Chen M, Yang XY, et al. Antihelminth compound niclosamide downregulates
Wnt signaling and elicits antitumor responses in tumors with activating APC mutations.
11. Rehman M, Asadullah Madni AI, Khan WS, et al. Solid and liquid lipid-based binary solid
13. Kim B-D, Na K, Choi H-K. Preparation and characterization of solid lipid nanoparticles
(SLN) made of cacao butter and curdlan. European journal of pharmaceutical sciences.
2005;24(2):199-205.
14. Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles:
2006;58(15):1688-1713.
16. Dubes A, Parrot-Lopez H, Abdelwahed W, et al. Scanning electron microscopy and atomic
282.
17. Fang J-Y, Fang C-L, Liu C-H, Su Y-H. Lipid nanoparticles as vehicles for topical psoralen
delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
19. Griffiths PR, De Haseth JA. Fourier transform infrared spectrometry. Vol 171: John Wiley
21. Bhardwaj U, Burgess DJ. A novel USP apparatus 4 based release testing method for
22. Zaher H, Khan AA, Palandra J, Brayman TG, Yu L, Ware JA. Breast cancer resistance
2013;15(10):1368-1374.
24. Van Tonder EC, Mahlatji MD, Malan SF, et al. Preparation and physicochemical
2004;5(1):86-95.
26. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. European journal
27. Kumar PP, Gayatri P, Sunil R, Jagamohan S, Rao YM. Atorvastatin loaded solid lipid
nanoparticles: formulation, optimization, and in vitro characterization. Int Organ Sci Res J
Pharm. 2012;2:23-32.
2007;328(2):191-195.
29. Duchêne D, Ponchel G. Bioadhesion of solid oral dosage forms, why and how? European
30. Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery
31. Song K-H, Chung S-J, Shim C-K. Enhanced intestinal absorption of salmon calcitonin
2005;106(3):298-308.
32. Venkatesan N, Uchino K, Amagase K, Ito Y, Shibata N, Takada K. Gastro-intestinal patch
26.